Legend Biotech Corp (LEGN) shareholders
Close on Nov 17, 2026Market cap $2.98BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| GenScript Biotech Corporation | 174,497,556 | 47.99% | 13G (passive) amendment | Dec 31, 2023 |
| FMR LLC Joint filing with Abigail P. Johnson (15.00%) | 57,996,198 | 15.00% | 13G (passive) amendment | Jun 30, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (12.40%) | 48,164,808 | 12.40% | 13G (passive) amendment | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LEGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 29,093,899 | 7.87% | $840.23M | +3,397,159 | 0.04% |
| Deerfield Management Company, L.P. (Series C) | 8,137,638 | 2.20% | $235.01M | +450,000 | 2.45% |
| Suvretta Capital Management, LLC | 7,070,000 | 1.91% | $204.18M | −511,029 | 3.73% |
| Hhlr Advisors, Ltd. | 5,984,550 | 1.62% | $172.83M | – | 20.77% |
| BlackRock, Inc. | 4,726,534 | 1.28% | $136.50M | +41,991 | 0.00% |
| Westfield Capital Management Co LP | 4,430,063 | 1.20% | $127.94M | −1,333,412 | 0.42% |
| Assenagon Asset Management S.A. | 3,830,112 | 1.04% | $110.61M | New | 0.07% |
| Goldman Sachs Group Inc | 3,662,315 | 0.99% | $105.77M | +2,198,203 | 0.01% |
| Point72 Asset Management, L.P. | 3,076,124 | 0.83% | $88.84M | −809,893 | 0.10% |
| Kynam Capital Management, LP | 3,001,205 | 0.81% | $86.67M | +1,424,910 | 4.79% |
| Artisan Partners Limited Partnership | 1,559,441 | 0.42% | $45.04M | −695,047 | 0.07% |
| State Street Corp | 1,498,704 | 0.41% | $43.29M | +332 | 0.00% |
| Capital International Investors | 1,420,654 | 0.38% | $41.03M | +772,804 | 0.01% |
| Morgan Stanley | 1,394,531 | 0.38% | $40.27M | +791,284 | 0.00% |
| Soleus Capital Management, L.P. | 1,205,000 | 0.33% | $34.80M | New | 1.20% |
| Davern Capital Partners, LP | 1,191,522 | 0.32% | $34.41M | −123,226 | 5.87% |
| Driehaus Capital Management LLC | 1,158,808 | 0.31% | $33.47M | New | 0.19% |
| Renaissance Technologies LLC | 1,000,200 | 0.27% | $28.89M | +478,400 | 0.04% |
| Ghisallo Capital Management LLC | 1,000,000 | 0.27% | $28.88M | New | 0.57% |
| Matthews International Capital Management LLC | 917,266 | 0.25% | $26.49M | −8,654 | 9.08% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 218 | 105M | 28.4% | 55 / 62 | 78 / 26 | 24M | 15M |
| Q1 2026 | 191 | 96M | 26.0% | 33 / 80 | 49 / 40 | 18M | 9M |
| Q4 2025 | 200 | 88M | 23.8% | 36 / 70 | 64 / 35 | 18M | 14M |
| Q3 2025 | 200 | 84M | 22.7% | 25 / 87 | 55 / 34 | 6M | 7M |
| Q2 2025 | 211 | 85M | 22.9% | 36 / 71 | 86 / 30 | 20M | 22M |
| Q1 2025 | 208 | 87M | 23.4% | 29 / 75 | 80 / 31 | 8M | 21M |
| Q4 2024 | 211 | 99M | 26.9% | 39 / 94 | 52 / 35 | 22M | 14M |
| Q3 2024 | 208 | 92M | 24.7% | 44 / 70 | 70 / 16 | 12M | 7M |
| Q2 2024 | 181 | 92M | 24.9% | 31 / 79 | 50 / 37 | 14M | 9M |
| Q1 2024 | 192 | 88M | 23.7% | 26 / 88 | 59 / 38 | 9M | 9M |
| Q4 2023 | 206 | 87M | 23.6% | 34 / 93 | 58 / 27 | 10M | 9M |
| Q3 2023 | 200 | 86M | 23.3% | 23 / 72 | 69 / 15 | 6M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
140 funds held LEGN in Q2 2026, 6% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of LEGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity OTC Portfolio | 3,709,610 | 1.00% | $68.81M | 0.16% | Jul 31, 2026 |
| Select Pharmaceuticals Portfolio | 2,504,500 | 0.68% | $68.02M | 4.53% | May 31, 2026 |
| Select Health Care Portfolio | 2,000,000 | 0.54% | $54.32M | 0.94% | May 31, 2026 |
| VIP Contrafund Portfolio | 1,888,696 | 0.51% | $54.55M | 0.18% | Jun 30, 2026 |
| Fidelity Emerging Markets Fund | 1,729,100 | 0.47% | $32.07M | 0.30% | Jul 31, 2026 |
| Harbor Small Cap Growth Fund | 1,348,391 | 0.36% | $25.01M | 0.94% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 1,321,196 | 0.36% | $38.16M | 0.04% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,142,080 | 0.31% | $31.02M | 0.01% | May 31, 2026 |
| iShares Biotechnology ETF | 1,052,686 | 0.28% | $30.40M | 0.33% | Jun 30, 2026 |
| Fidelity Advisor Health Care Fund | 1,019,556 | 0.28% | $18.91M | 0.61% | Jul 31, 2026 |
| Artisan International Small-Mid Fund | 956,356 | 0.26% | $27.62M | 1.09% | Jun 30, 2026 |
| iShares Core MSCI Emerging Markets ETF | 825,168 | 0.22% | $22.41M | 0.01% | May 31, 2026 |
| Fidelity U.S. Equity Central Fund | 727,400 | 0.20% | $21.01M | 0.09% | Jun 30, 2026 |
| VIP Mid Cap Portfolio | 695,600 | 0.19% | $20.09M | 0.21% | Jun 30, 2026 |
| Fidelity China Region Fund | 653,039 | 0.18% | $12.11M | 0.47% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ying Huang | Chief Executive Officer, Director | 238,490 | 0.06% | Jul 2, 2026 |
| Carlos E. Santos | Chief Financial Officer | 19,676 | 0.01% | Sep 23, 2026 |
| Ingrid Zhang | Chief Executive Officer | 1,131,860 | 0.31% | Sep 16, 2026 |
| Alan Bash | Interim CEO | 35,142 | 0.01% | Aug 18, 2026 |
| Peter Salovey | Director | 75,096 | 0.02% | Nov 16, 2026 |
| Corazon (Corsee) D. Sanders | Director | 52,731 | 0.01% | Oct 1, 2026 |
| Tomas J. Heyman | Director | 53,720 | 0.01% | Sep 28, 2026 |
| Li Mao | Director | 65,316 | 0.02% | Sep 28, 2026 |
| Darren Xiaohui Ji | Director | 92,103 | 0.02% | Sep 28, 2026 |
| Patrick John Casey | Director | 69,590 | 0.02% | Sep 28, 2026 |
| Fangliang Zhang | Director | – | – | Mar 18, 2026 |
| Ye Wang | Director | 16 | 0.00% | Mar 18, 2026 |
| Robin Meng | Director | – | – | Mar 18, 2026 |
| Gareth Kung | Director | 31,486 | 0.01% | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Peter Salovey Director | Nov 13, 2026 | Buy | +10,000 | $8.95 | $89.50K | 75,096 |
| Peter Salovey Director | Nov 12, 2026 | Buy | +10,000 | $9.38 | $93.75K | 65,096 |
| Corazon (Corsee) D. Sanders Director | Sep 29, 2026 | Sale | −27,370 | $9.46 | $258.92K | 52,731 |
| Corazon (Corsee) D. Sanders Director | Sep 24, 2026 | Award | +20,986 | – | – | 80,101 |
| Tomas J. Heyman Director | Sep 24, 2026 | Award | +20,986 | – | – | 53,720 |
| Li Mao Director | Sep 24, 2026 | Award | +20,986 | – | – | 65,316 |
| Darren Xiaohui Ji Director | Sep 24, 2026 | Award | +28,330 | – | – | 92,103 |
| Patrick John Casey Director | Sep 24, 2026 | Award | +20,986 | – | – | 69,590 |
| Peter Salovey Director | Sep 24, 2026 | Award | +28,330 | – | – | 55,096 |
| Carlos E. Santos Chief Financial Officer | Sep 21, 2026 | Award | +19,676 | – | – | 19,676 |
| Carlos E. Santos Chief Financial Officer | Sep 21, 2026 | Sale | −5,430 | $9.14 | $49.63K | 14,246 |
| Ingrid Zhang Chief Executive Officer | Sep 15, 2026 | Award | +1,131,860 | – | – | 1,131,860 |
| Alan Bash Interim CEO | Aug 14, 2026 | Award | +4,908 | – | – | 35,142 |
| Patrick John Casey Director | Jun 30, 2026 | Sale | −6,000 | $14.80 | $88.80K | 48,604 |
| Ying Huang Chief Executive Officer, Director | Jun 30, 2026 | Gift | −3,382 | – | – | 238,490 |
| Ying Huang Chief Executive Officer, Director | Jun 25, 2026 | Sale | −5,566 | $14.78 | $82.27K | 241,872 |
| Ying Huang Chief Executive Officer, Director | Mar 25, 2026 | Sale | −9,936 | $8.77 | $87.14K | 247,438 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Legend Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 15,625 shares on Oct 14, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Corazon (Corsee) D. Sanders Director | Sep 29, 2026 | 13,685 | $258.91K | Sep 29, 2026 | Restricted Stock Vesting |
| Ying Huang Former Officer & Director | Sep 22, 2026 | 69,812 | $1.30M | Sep 22, 2026 | Stock Option Exercise |
| Carlos E. Santos Officer | Sep 22, 2026 | 2,715 | $50.85K | Sep 22, 2026 | Restricted Stock Vesting |
| Patrick John Casey Director | Jun 30, 2026 | 3,000 | $88.80K | Jun 30, 2026 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Jun 26, 2026 | 2,783 | $79.02K | Jun 26, 2026 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Mar 26, 2026 | 4,968 | $87.15K | Mar 26, 2026 | Restricted Stock Vesting |
| Yeung Jessie Officer | Mar 26, 2026 | 1,862 | $32.66K | Mar 26, 2026 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Dec 29, 2025 | 64,339 | $1.45M | Dec 26, 2025 | Restricted Stock Vesting |
| Corazon (Corsee) D. Sanders Director | Dec 29, 2025 | 969 | $22.06K | Dec 24, 2025 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Dec 29, 2025 | 61,467 | $1.41M | Dec 24, 2025 | Restricted Stock Vesting |
| GenScript Corporation Affiliate | Nov 17, 2025 | 203,586 | $6.17M | Nov 17, 2025 | See Remarks below |
| Patrick John Casey Director | Sep 26, 2025 | 1,000 | $33.29K | Sep 26, 2025 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Sep 24, 2025 | 1,370 | $45.21K | Sep 24, 2025 | Restricted Stock Vesting |
| Corazon (Corsee) D. Sanders Director | Sep 23, 2025 | 307 | $10.44K | Sep 23, 2025 | Restricted Stock Vesting |
| Ying Huang Officer, Director | Sep 23, 2025 | 1,357 | $46.11K | Sep 23, 2025 | Restricted Stock Vesting |
See a number that looks wrong?